Halaman 3 - Onkologi Ahli onkologi Terbaik di Israel - TOP-112 dokter

Direktur Residensi Bedah di Hadassah Medical Center, Dr. Pikarsky melatih para calon ahli bedah dalam prosedur kolorektal yang kompleks.

• Pengalaman lebih dari 35 tahun di bidang bedah dan spesialisasi kolorektal
• Dosen senior bidang bedah di Hebrew University sejak 2005
• Tersertifikasi dalam bedah umum dengan subspesialisasi bedah kolorektal
• Anggota aktif dari berbagai asosiasi bedah ternama

Dr. Auala Hubert memimpin Pusat Kanker Gastrointestinal di Hadassah Medical Center – spesialisasi dalam kanker pencernaan kompleks dengan pengalaman 30+ tahun.

• Sertifikasi dewan dalam onkologi dan radioterapi
• Spesialisasi dalam terapi berkas proton dan imunoterapi untuk kanker saluran cerna
• Anggota Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker
• Fasih berbahasa Inggris dan Ibrani untuk pasien internasional

Prof. Dr. Reuven Or adalah ahli hematologi dan spesialis transplantasi sumsum tulang terkemuka di Hadassah Medical Center, yang dianugerahi Menachem Begin Prize atas kontribusinya.

• Pengalaman 15+ tahun di bidang hematologi dan transplantasi sumsum tulang
• Kepala Hematologi dan Transplantasi Sumsum Tulang di Hadassah
• Direktur Medis Bank Darah Nasional Israel
• Menerbitkan berbagai artikel di jurnal medis

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Peneliti terkemuka dalam kanker payudara terkait BRCA – Dr. Kaduri berspesialisasi dalam mutasi genetik di Hadassah Medical Center.

• Melakukan penelitian terobosan di Rumah Sakit Royal Marsden
• Mempublikasikan tentang Oncotype Dx pada pembawa mutasi BRCA1/2
• Dianugerahi Cancer Genetics Research Foundation Award
• Anggota Masyarakat Onkologi Klinis Israel

Spesialisasi dalam kanker tiroid stadium lanjut serta tumor kepala & leher dengan terapi biologis yang dipersonalisasi di Hadassah Medical Center.

• Direktur Onkologi di Hadassah – salah satu pusat kanker terkemuka di Israel
• Menjalani pelatihan fellowship di Memorial Sloan Kettering dalam teknik bedah radio (radiosurgery)
• Berpengalaman 20+ tahun yang berfokus pada onkologi kepala & leher serta radioterapi
• Mantan Kepala Onkologi Kepala & Leher di Davidoff Cancer Center

Dr. Rinat Erushalmi berspesialisasi dalam mengobati subtipe kanker payudara yang menantang di Rabin Medical Center, rumah sakit onkologi terkemuka di Israel.

• Ahli dalam Kanker Payudara HER-2 Positif dan Triple-Negative
• Dinilai sangat tinggi oleh pasien dalam 6 kondisi
• Berspesialisasi dalam perawatan terkait hormon dan bedah pengurangan risiko
• Praktik di Rabin Medical Center – pusat kanker terbesar di Israel

Kepala departemen bedah onkologi di Rabin Medical Center – Dr. Nejman memimpin studi klinis tingkat lanjut dalam onkourologi.

• 25+ tahun spesialisasi dalam kanker urologi dan payudara
• Memimpin berbagai uji klinis internasional untuk perawatan baru
• Sering diundang sebagai pembicara di forum onkologi utama
• Anggota dari berbagai perkumpulan onkologi internasional

Spesialis endoprostetik – Dr. Dekel berfokus pada penggantian sendi buatan yang sering kali diperlukan setelah operasi tumor tulang yang kompleks di Assuta Medical Center.

• Ahli dalam rekonstruksi anggota gerak dan bedah pengangkatan tumor
• Berfokus pada penggantian sendi untuk kanker muskuloskeletal
• Berbasis di Assuta Medical Center

Dr. Hirsch berspesialisasi dalam gastroenterologi di Assuta Medical Center, sebuah rumah sakit swasta terkemuka di Israel.

• Ahli dalam skrining dan manajemen kanker kolon
• Fokus pada prosedur endoskopi yang presisi
• Spesialis dalam kondisi gastrointestinal

Spesialisasi dalam prosedur laringektomi di Assuta Medical Center – pemimpin dalam perawatan THT tingkat lanjut.

• Berfokus pada kanker kepala dan leher dalam otolaringologi
• Mengobati kondisi tenggorokan dan laring yang kompleks
• Bagian dari tim onkologi khusus di rumah sakit swasta terkemuka

Spesialis bedah bariatrik di Assuta Medical Center.

• Berfokus pada prosedur penurunan berat badan
• Bekerja di salah satu pusat medis terkemuka di Israel
• Berpengalaman dalam intervensi bedah untuk obesitas